Chew et al., 2020 - Google Patents
Ultrahigh packing density next generation microtube array membrane: A novel solution for absorption‐based extracorporeal endotoxin removal deviceChew et al., 2020
View PDF- Document ID
- 8147361919392482767
- Author
- Chew C
- Cheng L
- Huang W
- Wu Y
- Lee C
- Wu M
- Chen C
- Publication year
- Publication venue
- Journal of Biomedical Materials Research Part B: Applied Biomaterials
External Links
Snippet
Sepsis is a deadly disease that is widely attributed to endotoxin released by gram‐negative bacterial infections often plague emergency care facilities. Conventionally antibiotics and vasopressors are used to treat this disease. Recent treatment protocol shifted to a …
- 239000012528 membrane 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chew et al. | Ultrahigh packing density next generation microtube array membrane: A novel solution for absorption‐based extracorporeal endotoxin removal device | |
Zhang et al. | Biocompatibility evaluation of ePTFE membrane modified with PEG in atmospheric pressure glow discharge | |
JP5774607B2 (en) | Removal of toxic factors by in vitro treatment | |
Ye et al. | Neutrophil extracellular traps-inspired DNA hydrogel for wound hemostatic adjuvant | |
Xu et al. | Silk fibroin/chitosan hydrogel with antibacterial, hemostatic and sustained drug‐release activities | |
Zhang et al. | Anticoagulant Hydrogel Tubes with Poly (ɛ‐Caprolactone) Sheaths for Small‐Diameter Vascular Grafts | |
Li et al. | Poly (pentahydropyrimidine)‐based hybrid hydrogel with synergistic antibacterial and pro‐angiogenic ability for the therapy of diabetic foot ulcers | |
BR112016024569B1 (en) | EX VIVO METHOD FOR REMOVING BACTERIA FROM A SPECIMEN TAKEN FROM AN INDIVIDUAL WHO IS SUSPECTED TO BE INFECTED WITH THE SAME | |
US20220072038A1 (en) | Method for modulating endothelial glycocalyx structure | |
CA2055515A1 (en) | High efficiency removal of low density lipoprotein-cholesterol from whole blood | |
Zheng et al. | In vitro hemocompatibility and hemodialysis performance of hydrophilic ionic liquid grafted polyethersulfone hollow fiber membranes | |
Piran et al. | Electrospun triple‐layered PLLA/gelatin. PRGF/PLLA scaffold induces fibroblast migration | |
Karahaliloğlu et al. | Active nano/microbilayer hemostatic agents for diabetic rat bleeding model | |
Selvaras et al. | Biodegradable and antithrombogenic chitosan/elastin blended polyurethane electrospun membrane for vascular tissue integration | |
Ye et al. | Synthesis, characterization, properties, and biomedical application of chitosan-based hydrogels | |
Xu et al. | Microfluidic generation of multifunctional core-shell microfibers promote wound healing | |
Wei et al. | By endowing polyglutamic acid/polylysine composite hydrogel with super intrinsic characteristics to enhance its wound repair potential | |
Woźniak-Budych | Polymeric membranes for biomedical applications | |
JP2006291193A (en) | Reformed substrate and manufacturing method thereof | |
Vorobii et al. | Antifouling microparticles to scavenge lipopolysaccharide from human blood plasma | |
Hou et al. | A heparin modified polypropylene non‐woven fabric membrane adsorbent for selective removal of low density lipoprotein from plasma | |
Zhang et al. | An injectable integration of autologous bioactive concentrated growth factor and gelatin methacrylate hydrogel with efficient growth factor release and 3D spatial structure for accelerated wound healing | |
Ling et al. | Rational design of hemocompatible hydrogel microspheres towards pathogen-associated molecular patterns removal for Gram-positive bacteria-induced sepsis | |
Xu et al. | Complexation‐Induced Resolution Enhancement Pleiotropic Small Diameter Vascular Constructs with Superior Antibacterial and Angiogenesis Properties | |
Li et al. | Sprayable self‐assembly multifunctional bioactive poly (ferulic acid) hydrogel for rapid MRSA infected wound repair |